References
- Ahmad R, Al-Mass A, Atizado V, et al. (2012). Elevated expression of the toll like receptors 2 and 4 in obese individuals: Its significance for obesity-induced inflammation. J Inflamm (Lond) 9:48
- Akash MS, Rehman K, Chen S. (2013). Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem 114:525–31
- Cai K, Qi D, Hou X, et al. (2011). MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2. PLoS One 6:e19559
- Chavez SA, Martinko AJ, Lau C, et al. (2011). Development of β-amino alcohol derivatives that inhibit Toll-like receptor 4 mediated inflammatory response as potential antiseptics. J Med Chem 54:4659–69
- Cui G, Qin X, Zhang Y, et al. (2009). Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J Biol Chem 284:28420–9
- Du P, Fan B, Han H, et al. (2013). NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 84:265–76
- Edalat B, Sharifi F, Badamchizadeh Z, et al. (2013). Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J Diabetes Metab Disord 12:8
- Hamidi A, von Bulow V, Hamidi R, et al. (2012). Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli. J Biol Chem 287:123–33
- Hellemans K, Kerckhofs K, Hannaert JC, et al. (2007). Peroxisome proliferator-activated receptor alpha-retinoid X receptor agonists induce beta-cell protection against palmitate toxicity. FEBS J 274:6094–105
- Hussey SE, Liang H, Costford SR, et al. (2012). TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells. Biosci Rep 33:37–47
- Li J, Wang X, Zhang F, Yin H. (2013). Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol Ther 138:441–51
- Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. (2013). Diabetes mellitus and inflammation. Curr Diab Rep 13:435–44
- Ma L, Dong F, Zaid M, et al. (2012). ABCA1 protein enhances Toll-like receptor 4 (TLR4)-stimulated interleukin-10 (IL-10) secretion through protein kinase A (PKA) activation. J Biol Chem 287:40502–12
- Mangan DF, Wahl SM. (1991). Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 147:3408–12
- Russell MA, Cooper AC, Dhayal S, Morgan NG. (2013). Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells. Islets 5:95–105
- Shen N, Huan Y, Shen ZF. (2012). Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell. Eur J Pharmacol 694:120–6
- Song Y, Dou H, Gong W, et al. (2013). bis-N-Norgliovictin, a small-molecule compound from marine fungus, inhibits LPS-induced inflammation in macrophages and improves survival in sepsis. Eur J Pharmacol 705:49–60
- Wu D, Wen W, Qi CL, et al. (2012). Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine 19:712–18
- Zhang Q, Piao XL, Piao XS, et al. (2011). Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol 49:61–9
- Zohn IE, Yu H, Li X, et al. (1995). Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol 15:6160–8